D'ORONZO, STELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.720
AS - Asia 1.157
SA - Sud America 678
EU - Europa 387
AF - Africa 106
OC - Oceania 2
Totale 4.050
Nazione #
US - Stati Uniti d'America 1.671
BR - Brasile 528
SG - Singapore 329
VN - Vietnam 313
CN - Cina 268
DE - Germania 114
IT - Italia 75
AR - Argentina 64
BD - Bangladesh 61
MA - Marocco 61
HK - Hong Kong 47
FR - Francia 43
FI - Finlandia 35
ID - Indonesia 29
EC - Ecuador 26
MX - Messico 21
PK - Pakistan 19
GB - Regno Unito 18
PL - Polonia 18
IN - India 17
ZA - Sudafrica 17
PY - Paraguay 16
CA - Canada 15
AT - Austria 14
RU - Federazione Russa 14
NL - Olanda 12
CL - Cile 11
PE - Perù 11
CO - Colombia 9
IQ - Iraq 9
UA - Ucraina 9
ES - Italia 8
TR - Turchia 8
SE - Svezia 7
TN - Tunisia 7
EG - Egitto 6
JP - Giappone 6
KZ - Kazakistan 6
PH - Filippine 6
UY - Uruguay 6
KE - Kenya 5
MY - Malesia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
DZ - Algeria 4
JO - Giordania 4
AO - Angola 3
DO - Repubblica Dominicana 3
IL - Israele 3
JM - Giamaica 3
RO - Romania 3
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
CR - Costa Rica 2
EE - Estonia 2
GT - Guatemala 2
KH - Cambogia 2
KR - Corea 2
KW - Kuwait 2
LK - Sri Lanka 2
PA - Panama 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CH - Svizzera 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TW - Taiwan 1
Totale 4.050
Città #
Dallas 1.125
Singapore 159
Ho Chi Minh City 137
San Jose 115
Ashburn 84
Frankfurt am Main 80
The Dalles 70
Hefei 65
Casablanca 57
Hanoi 51
Hong Kong 43
São Paulo 37
Beijing 33
Helsinki 33
Los Angeles 29
Columbus 20
New York 20
Islamabad 18
Chicago 15
Da Nang 14
Haiphong 14
Hillsboro 13
Warsaw 13
Munich 12
Belo Horizonte 11
Campinas 11
Thái Bình 11
Brasília 10
Milan 10
Nuremberg 10
Brooklyn 9
Curitiba 9
Vienna 9
Amsterdam 8
Asunción 8
Quito 8
Rio de Janeiro 8
Buenos Aires 7
Fortaleza 7
Lima 7
Orem 7
Santa Clara 7
Stockholm 7
Bari 6
Biên Hòa 6
Dhaka 6
Düsseldorf 6
Guarulhos 6
Guayaquil 6
Ha Long 6
Jakarta 6
Johannesburg 6
Osasco 6
Salvador 6
Hải Dương 5
Maceió 5
Mauá 5
Mexico City 5
Nairobi 5
Ninh Bình 5
Phủ Lý 5
Porto Alegre 5
Portsmouth 5
Rome 5
Santo André 5
Sorocaba 5
Thái Nguyên 5
Tokyo 5
Almaty 4
Bogotá 4
Buffalo 4
Caraguatatuba 4
Córdoba 4
Londrina 4
Manaus 4
Manchester 4
Montevideo 4
Nova Iguaçu 4
Posadas 4
Recife 4
Reston 4
Riyadh 4
Roubaix 4
San Francisco 4
Toronto 4
Amman 3
Araçatuba 3
Bauru 3
Bắc Giang 3
Bắc Ninh 3
Camaçari 3
Chennai 3
Istanbul 3
Juiz de Fora 3
Kuala Lumpur 3
Limburg an der Lahn 3
Macerata 3
Mumbai 3
Nova Friburgo 3
Presidente Prudente 3
Totale 2.670
Nome #
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 589
10-year patterns of recurrence from early breast cancer: Analyses of the AZURE (BIG 01/04) study of adjuvant zoledronic acid 578
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 90
Bone-sialoprotein (BSP), Dickkopf-1 (DKK1) and CXCR4 as potential biomarkers of breast cancer metastasis to bone: Analysis within the AZURE (BIG 01/04) study of adjuvant zoledronic acid 72
Conservative Treatments in the Management of Acute Painful Vertebral Compression Fractures: A Systematic Review and Network Meta-Analysis 65
Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experience 65
Cancer Treatment and Bone Health 65
Bone metastases in hepatocellular carcinoma: an emerging issue 64
Breast cancer: an update on treatment-related infertility 63
[Bone health in the oncologic patient]. FT La "bone health" nel paziente oncologico 61
Bone Metastases from Solid Tumors: In Search of Predictive Biomarkers for Clinical Translation 60
Ddx4+ Oogonial Stem Cells in Postmenopausal Women's Ovaries: A Controversial, Undefined Role 59
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications 59
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 53
Bone Metastases; Clinical Aspects 52
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 52
Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma 52
Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art 51
Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle 50
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in adults: Recommendations From the European Calcified Tissue Society 49
[Cell-based strategies: novel perspectives for cancer therapy]. FT Terapie cellulari in oncologia: recenti acquisizioni e sviluppi futuri 48
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis 47
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 47
Osteotropism of neuroendocrine tumors: Role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro 47
Uterine carcinosarcoma: An overview 46
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 45
Perspective in infertility: the ovarian stem cells 45
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group 44
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 44
Pulmonary enteric adenocarcinoma: An overview 43
Tamoxifen and Fertility in Women with Breast Cancer: A Systematic Review on Reproductive Outcomes and Oncological Safety of Treatment Interruption 43
Therapeutic approaches to myeloma bone disease: An evolving story 43
In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization 42
DEAD-Box Helicase 4 (Ddx4)+ Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers 42
In Vitro Generation of Oocytes from Ovarian Stem Cells (OSCs): In Search of Major Evidence 42
Fertility preservation techniques in cervical carcinoma 42
Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations 41
Fertility Preservation in the Era of Immuno-Oncology: Lights and Shadows 41
Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management 41
Ovarian cancer: Novel molecular aspects for clinical assessment 39
Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis 39
Liquid biopsy in cervical cancer: Hopes and pitfalls 39
The role of biomarkers in the management of bone-homing malignancies 39
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer 38
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update 38
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper 38
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view 38
Molecular Assessment of Ovarian Cancer and Translation to Clinical Management 37
The use of bisphosphonates to treat skeletal complications in solid tumours 37
Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer 37
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 35
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 35
Reply: Improved understanding of very small embryonic-like stem cells in adult mammalian ovary 35
The value of biomarkers in bone metastasis 35
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients 35
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 34
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 34
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view 34
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 33
Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 33
Correlation between targeted RNAseq signature of breast cancer CTCs and onset of bone-only metastases 33
Late endocrine-metabolic complications in survivors of young adult and adult-onset cancers: comprehensive evaluation and strategies for management. An Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical review 32
Medical Prevention and Treatment of Bone Metastases 31
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper 30
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer 28
Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences 28
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies 18
Treating osteoporosis with denosumab or bisphosphonates in the long term: facts, uncertainties and assumptions. A narrative review by the clinical action group of the European Calcified Tissue Society (ECTS) 18
Targeting the Tumor Microenvironment in Hodgkin Lymphoma: Challenges and Therapeutic Strategies 16
Mechanisms of Action of Ready-to-Use Therapies in Hematologic Malignancies: From Clinical Impact to Future Directions 16
Bone metastases; clinical aspects 14
Bone Adverse Events in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Comprehensive Review of the Literature from the Clinical Action Group of the European Calcified Tissue Society 9
Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational study 6
Totale 4.123
Categoria #
all - tutte 21.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025480 0 0 0 117 18 89 6 47 52 40 90 21
2025/20263.643 35 422 1.215 856 56 65 287 204 114 206 91 92
Totale 4.123